Pediatric-onset glaucoma of genetic origin

Pediatric-onset glaucoma of genetic origin (also known as primary congenital glaucoma, infantile glaucoma, or developmental glaucoma) is a group of rare inherited eye disorders characterized by elevated intraocular pressure (IOP) due to developmental abnormalities of the anterior chamber angle of the eye, specifically the trabecular meshwork and drainage structures. This increased pressure damages the optic nerve and, if untreated, leads to progressive and irreversible vision loss. The condition primarily affects the ocular system, and in young children the elevated pressure can also cause enlargement of the eye (buphthalmos), corneal edema and clouding, excessive tearing (epiphora), light sensitivity (photophobia), and blepharospasm. The disease may present at birth or during early childhood, and can affect one or both eyes, though bilateral involvement is more common. Several genes have been implicated in pediatric-onset glaucoma of genetic origin. The most well-characterized is CYP1B1 (cytochrome P450 1B1), associated with autosomal recessive primary congenital glaucoma (GLC3A). Mutations in LTBP2 (GLC3D) and TEK (also known as TIE2) have also been identified. Additionally, mutations in MYOC and FOXC1 can cause juvenile-onset open-angle glaucoma or anterior segment dysgenesis with secondary glaucoma. The genetic heterogeneity of this condition means that inheritance patterns can vary depending on the specific genetic subtype, though autosomal recessive inheritance is the most common pattern, particularly for primary congenital glaucoma. The primary treatment for pediatric-onset glaucoma is surgical, as medical therapy alone is generally insufficient to control intraocular pressure in children. Goniotomy and trabeculotomy are the first-line surgical procedures, aiming to improve aqueous humor outflow by opening the abnormal drainage angle. In refractory cases, trabeculectomy, glaucoma drainage devices, or cyclodestructive procedures may be necessary. Topical and systemic IOP-lowering medications (beta-blockers, carbonic anhydrase inhibitors, prostaglandin analogs) are used as adjunctive therapy. Early diagnosis and prompt surgical intervention are critical to preserving vision. Long-term follow-up is essential, as these patients require lifelong monitoring for IOP control, amblyopia management, and refractive correction.

Common questions about Pediatric-onset glaucoma of genetic origin